Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein

Molecular and Cellular Proteomics

Volumn 10, Issue 5, 2011, Pages

  De Laurentiis, Annamaria ^a   Gaspari, Marco ^a   Palmieri, Camillo ^a   Falcone, Cristina ^a   Iaccino, Enrico ^a   Fiume, Giuseppe ^a   Massa, Ornella ^b   Masullo, Mariorosario ^c,d   Tuccillo, Franca Maria ^e   Roveda, Laura ^f   Prati, Ubaldo ^f   Fierro, Olga ^g   Cozzolino, Immacolata ^d   Troncone, Giancarlo ^d   Tassone, Pierfrancesco ^h   Scala, Giuseppe ^a,d   Quinto, Ileana ^a,d  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f Cancer Center of Excellence   (Italy)

^g CNR   (Italy)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCERR ANTIGEN UN 1; LEUKOSIALIN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; EPITOPE; MONOCLONAL ANTIBODY; N ACETYLGALACTOSAMINE; SPN PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANTIGEN PURIFICATION; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; CROSS REACTION; ELECTROPHORESIS; GENE EXPRESSION; GLYCOSYLATION; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MASS SPECTROMETRY; PRIORITY JOURNAL; BREAST TUMOR; CHEMISTRY; COLORECTAL TUMOR; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ACETYLGALACTOSAMINE; AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD43; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EPITOPES; FEMALE; GLYCOSYLATION; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; TANDEM MASS SPECTROMETRY;

EID: 79955750270     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.007898     Document Type: Article

References (38)

1. Ohtsubo, K., and Marth, J. D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867
2. Wopereis, S., Lefeber, D. J., Morava, E., and Wevers, R. A. (2006) Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. Clin. Chem. 52, 574-600
3. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl. Acad. Sci. U.S.A. 99, 10231-10233
4. Brockhausen, I. (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 7, 599-604
5. Tassone, P., Bond, H., Bonelli, P., Tuccillo, F., Valerio, G., Petrella, A., Lamberti, A., Cecco, L., Turco, M. C., Cerra, M., et al. (1994) UN1, a murine monoclonal antibody recognizing a novel human thymic antigen. Tissue Antigens 44, 73-82 (Pubitemid 24262459)
6. Cecco, L., Bond, H. M., Bonelli, P., Tuccillo, F., Cerra, M., Tassone, P., Sorice, R., Lamberti, A., Morrone, G., and Venuta, S. (1998) Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues. Tissue Antigens 51, 528-535 (Pubitemid 28269222)
7. Tassone, P., Tuccillo, F., Bonelli, P., D'Armiento, F. P., Bond, H. M., Palmieri, C., Tagliaferri, P., and Venuta, S. (2002) Fetal ontogeny and tumor expression of the early thymic antigen UN1. Int. J. Oncol. 20, 707-711
8. Tassone, P., Bonelli, P., Tuccillo, F., Bond, H. M., D'Armiento, F. P., Galea, E., Palmieri, C., Tagliaferri, P., Natali, P. G., and Venuta, S. (2002) Differential expression of UN1, early thymocyte-associated sialoglyco-protein, in breast normal tissue, benign disease and carcinomas. Anticancer Res. 22, 2333-2340 (Pubitemid 34857062)
9. Mallardo, M., Dragonetti, E., Baldassarre, F., Ambrosino, C., Scala, G., and Quinto, I. (1996) An NF-kappaB site in the 5′-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli. J. Biol. Chem. 271, 20820-20827
10. de Laurentiis, A., Caterino, M., Orrù, S., Ruoppolo, M., Tuccillo, F., Masullo, M., Quinto, I., Scala, G., Pucci, P., Palmieri, C., Tassone, P., Salvatore, F., and Venuta, S. (2006) Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein. Int. J. Biol. Macromol. 39, 122-126
11. Gaspari, M., Abbonante, V., and Cuda, G. (2007) Gel-free sample preparation for the nanoscale LC-MS/MS analysis and identification of low-nanogram protein samples. J. Sep. Sci. 30, 2210-2216
12. Blixt, O., Head, S., Mondala, T., Scanlan, C., Huflejt, M. E., Alvarez, R., Bryan, M. C., Fazio, F., Calarese, D., Stevens, J., Razi, N., Stevens, D. J., Skehel, J. J., van Die, I., Burton, D. R., Wilson, I. A., Cummings, R., Bovin, N., Wong, C. H., and Paulson, J. C. (2004) Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. U.S.A. 101, 17033-17038
13. Carlsson, S. R., and Fukuda, M. (1986) Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. J. Biol. Chem. 261, 12779-12786
14. Fukuda, M., and Tsuboi, S. (1999) Mucin-type O-glycans and leukosialin. Biochim. Biophys. Acta 1455, 205-217
15. Remold-O'Donnell, E., Kenney, D. M., Parkman, R., Cairns, L., Savage, B., and Rosen, F. S. (1984) Characterization of a human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome. J. Exp. Med. 159, 1705-1723
16. Fukuda, M. (1991) Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy. Glycobiology 1, 347-356
17. Cyster, J. G., Shotton, D. M., and Williams, A. F. (1991) The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J. 10, 893-902
18. Van Dyken, S. J., Green, R. S., and Marth, J. D. (2007) Structural and mechanistic features of protein O-glycosylation linked to CD8+ T-cell apoptosis. Mol. Cell. Biol. 27, 1096-1111
19. Piller, F., Le Deist, F., Weinberg, K. I., Parkman, R., and Fukuda, M. (1991) Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome. J. Exp. Med. 173, 1501-1510
20. Higgins, E. A., Siminovitch, K. A., Zhuang, D. L., Brockhausen, I., and Dennis, J. W. (1991) Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J. Biol. Chem. 266, 6280-6290
21. Bierhuizen, M. F., Maemura, K., and Fukuda, M. (1994) Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase. J. Biol. Chem. 269, 4473-4479
22. Rosenstein, Y., Park, J. K., Hahn, W. C., Rosen, F. S., Bierer, B. E., and Burakoff, S. J. (1991) CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 354, 233-235 (Pubitemid 21896822)
23. Matsumoto, M., Atarashi, K., Umemoto, E., Furukawa, Y., Shigeta, A., Miyasaka, M., and Hirata, T. (2005) CD43 functions as a ligand for E-Selectin on activated T cells. J. Immunol. 175, 8042-8050 (Pubitemid 41798366)
24. Pedraza-Alva, G., Mérida, L. B., Burakoff, S. J., and Rosenstein, Y. (1998) T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. J. Biol. Chem. 273, 14218-14224
25. Mambole, A., Baruch, D., Nusbaum, P., Bigot, S., Suzuki, M., Lesavre, P., Fukuda, M., and Halbwachs-Mecarelli, L. (2008) The cleavage of neutrophil leukosialin (CD43) by cathepsin G releases its extracellular domain and triggers its intramembrane proteolysis by presenilin/gamma-secretase. J. Biol. Chem. 283, 23627-23635
26. Seo, W., and Ziltener, H. J. (2009) CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis. Blood 114, 3567-3577
27. Hernandez, J. D., Nguyen, J. T., He, J., Wang, W., Ardman, B., Green, J. M., Fukuda, M., and Baum, L. G. (2006) Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death. J. Immunol. 177, 5328-5336
28. Santamaría, M., López-Beltrán, A., Toro, M., Peña, J., and Molina, I. J. (1996) Specific monoclonal antibodies against leukocyte-restricted cell surface molecule CD43 react with nonhematopoietic tumor cells. Cancer Res. 56, 3526-3529 (Pubitemid 26251647)
29. Sikut, R., Nilsson, O., Baeckström, D., and Hansson, G. C. (1997) Colon adenoma and cancer cells aberrantly express the leukocyte-associated sialoglycoprotein CD43. Biochem. Biophys. Res. Commun. 238, 612-616
30. Sikut, R., Andersson, C. X., Sikut, A., Fernandez-Rodriguez, J., Karlsson, N. G., and Hansson, G. C. (1999) Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain. Int. J. Cancer 82, 52-58
31. Santana, M. A., Pedraza-Alva, G., Olivares-Zavaleta, N., Madrid-Marina, V., Horejsi, V., Burakoff, S. J., and Rosenstein, Y. (2000) CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes. J. Biol. Chem. 275, 31460-31468
32. Springer, G. F. (1997) Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. J. Mol. Med. 75, 594-602
33. Terasawa, K., Furumoto, H., Kamada, M., and Aono, T. (1996) Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells. Cancer Res. 56, 2229-2232 (Pubitemid 26119930)
34. Konno, A., Hoshino, Y., Terashima, S., Motoki, R., and Kawaguchi, T. (2002) Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin. Exp. Metastasis 19, 61-70
35. Kumar, S. R., Sauter, E. R., Quinn, T. P., and Deutscher, S. L. (2005) Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Clin. Cancer Res. 11, 6868-6871
36. Kawaguchi, T., Takazawa, H., Imai, S., Morimoto, J., Watanabe, T., Kanno, M., and Igarashi, S. (2006) Expression of Vicia villosa agglutinin (VVA)- binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA? Breast Cancer Res. Treat. 98, 31-43 (Pubitemid 44050778)
37. Pinho, S., Marcos, N. T., Ferreira, B., Carvalho, A. S., Oliveira, M. J., Santos-Silva, F., Harduin-Lepers, A., and Reis, C. A. (2007) Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. Cancer Lett. 249, 157-170
38. Li, Q., Anver, M. R., Butcher, D. O., and Gildersleeve, J. C. (2009) Resolving conflicting data on expression of the Tn antigen and implications for clinical trials with cancer vaccines. Mol. Cancer Ther. 8, 971-979